Sanofi's Paul Hudson out, with Belén Garijo to step in as new CEO

Reynald Castañeda / endpoints - Paul Hudson is stepping down from his post as CEO of Sanofi, and his last day will be Feb. 17. The French drugmaker's board decided not to renew Hudson's mandate on ...

AI Summary: Sanofi’s board has opted not to renew Paul Hudson’s tenure, installing Belén Garijo as the new chief executive amid mixed reactions. The leadership swap arrives as the French drugmaker faces pipeline pressures and investor impatience—expect strategic shuffles, belt‑tightening and plenty of corporate soul‑searching with a side of investor scrutiny.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

First-in-human trial primes immune system to accept donor livers / 6 wks

Experimental therapy significantly reduces Parkinson’s toxic protein in early trial / 7 wks

Keratin 16 restrains skin inflammation and may guide treatments / 7 wks

Belzutifan combinations highlighted at ASCO GU improve RCC outcomes / 2 months

FDA lifts holds on Intellia’s Phase 3 gene-editing trials / 2 months

Rezatapopt shows proof-of-concept reactivating mutant p53 in patients / 2 months

Perioperative enfortumab vedotin plus pembrolizumab improves outcomes in MIBC / 3 months